The Parkinson Study Group (PSG) is a non-profit, cooperative group of Parkinson's disease experts from medical centers in the United States and Canada who are dedicated to improving treatment for persons affected by Parkinson's disease.
PSG Overview
.
Information about the QE3 trial is now available. Read more...
22nd Annual Symposium on Etiology, Pathogenesis, and Treatment of
Parkinson's Disease and Other Movement Disorders
Sunday, September 21, 2008
The Grand America Hotel, Salt Lake City, UtahAn abbreviated program is available...read more...
Updated August 2008
Parkinson Study Group: Request for Proposals
for Retrospective Data-Mining Projects and Other General Research
for Parkinson’s Disease and Related Disorders
The above PSG Request for Proposals is now closed.
Proposals received will be reviewed by the PSG Scientific Review Committee.
Applicants will be notified of the results by October 15, 2008.For more information about the RFP, (read more...)
The PROGENI trial is also accepting participants.
Please see PROGENI for more information. Thank you.The Parkinson Study Group proudly endorses the PDTrials.org Campaign. PDTrials.org is the umbrella name for a dedicated effort to accelerate the development of new treatments for Parkinson’s disease. This campaign is being led by the Parkinson’s Disease Foundation, in collaboration with Parkinson's disease advocacy groups. You will find up-to-date information on Parkinson's disease clinical trials currently enrolling participants in the U.S. by symptom and location, as well as the latest news and views on what's happening in the world of Parkinson's trials. Click on the button below to go to the PDTrials.org web site.
No medical questions, please.
